Global Innovative Platforms Inc. (GIPL)

Market Cap	2.52M -50.3%
Revenue (ttm)	187.20K
Net Income	-677.04K
EPS	-0.01
Shares Out	49.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Open	0.1000
Previous Close	0.5000
Day's Range	0.0506 - 0.1000
52-Week Range	0.0506 - 0.5200
Beta	9,063.83
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 30, 2026

About GIPL

Global Innovative Platforms Inc. engages in the business of testing breath to detect and assist in the treatment of disease. The company develops Heartworm breath test, which includes breath collection device, to collect shallow breath samples. It also operates VOCAM Plus and FROG platform for gas chromatography, as well as operates A.I. software to provide breath and air analysis. The company was formerly known as Canning Str Corp. and changed its name to Global Innovative Platforms Inc. in September 2021. Global Innovative Platforms Inc. was ...

• Industry: Shell Companies
• Sector: Financials
• Founded: 2020
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: GIPL

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 13, 2026

Data Sources Report a data error